Glaucoma

Pearls for managing COVID-19 pandemic north of the border

July 23, 2020

Canadian ophthalmologists receive updates on best practices amid coronavirus outbreak

Glaucoma drug delivery devices enter new frontier

July 22, 2020

Industry develops creative approaches to help increase patient medication adherence

Glaucoma devices: Now and in the future

July 21, 2020

Panel discusses IOP monitoring, drug delivery, data collection

Investigators target algorithm for diagnosing glaucoma

July 20, 2020

Research finds automated segmentation software examines OCT scans

Glaucoma 360: Lowering IOP using the MIMS solution

July 19, 2020

ICYMI: Nir Israeli, co-founder and CEO of Sanoculis discusses the company's new alternative surgical procedure for glaucoma designed to create a single-patient-use sterile tool and a multi-use external machine.

Beating burnout with camaraderie

July 17, 2020

For many physicians, “moral injury” may be actual issue

Glaucoma 360: Drug delivery contact lens technology

July 17, 2020

ICYMI: Chris Adams, CEO of Diopter Corp, discusses the company's drug delivery contact lens technology in the pipeline that works to treat ocular surface disease, during the 2020 Glaucoma 360 meeting in San Francisco, California.

Glaucoma 360: Pharmaceuticals in the glaucoma industry

July 16, 2020

ICYMI: Ramin Valian, vice president of International Glaucoma, Reimbursement and Pipeline at Allergan, discusses glaucoma from a therapeutics/diagnostics and big data sets standpoint during the 2020 Glaucoma 360 meeting.

Status of glaucoma: diagnostics and treatments in flux

July 16, 2020

High-level observations for how the latest developments can help glaucoma specialists solve problems to achieve the utmost in patient care

Next frontier in glaucoma: Beyond IOP-lowering treatments

July 15, 2020

Besides traditional medications, here are some of the many novel approaches to treat patients with glaucoma